Chemical classes designated as MER3 inhibitors encompass a range of compounds that interact with cellular mechanisms to influence the activity of the MER3 protein, a helicase involved in meiotic recombination and DNA repair processes. These inhibitors do not directly target MER3 itself but instead act upon various cellular pathways that are crucial for the proper functioning of MER3. The compounds typically target enzymes and other proteins that are either upstream or downstream in the signaling cascades associated with DNA repair and the cell cycle. For instance, inhibitors that affect kinases involved in cell cycle checkpoints can alter the cellular environment in a way that impacts the recruitment or activity of MER3 during meiosis or in response to DNA damage.
Inhibition of DNA repair pathways, such as homologous recombination and non-homologous end joining, is a common strategy employed by these chemicals. By modulating the activity of proteins like PARP, ATM, ATR, and DNA-PK, these inhibitors can lead to an increased reliance on alternative DNA repair mechanisms where MER3 plays a role. This shift in cellular reliance on DNA repair pathways can result in an indirect modulation of MER3 activity. Additionally, by targeting components of the MRN complex or the PI3K signaling pathway, these inhibitors can cause changes in the processing of DNA breaks and the initiation of repair processes that require MER3. The result is an alteration in the cellular dynamics that govern the fidelity and efficiency of meiotic recombination and the maintenance of genomic stability. It is essential to recognize that the activity of these inhibitors on MER3 function is a result of their impact on broader cellular processes. The nature of these interactions means that the inhibitors must be carefully examined within the context of the entire cellular network to understand their specific effects on MER3. These compounds are valuable tools for dissecting the intricate web of interactions that maintain genomic integrity and ensure the proper execution of meiotic recombination.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
NU7026 is a DNA-PK inhibitor, which could possibly inhibit MER3 by influencing the DNA repair pathways where MER3 may play a role. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
KU-55933 is an ATM kinase inhibitor, which could possibly inhibit MER3 by affecting the homologous recombination pathway. | ||||||
LY 303511 | 154447-38-8 | sc-202215 sc-202215A | 1 mg 5 mg | $67.00 $278.00 | 3 | |
LY294002 is a PI3K inhibitor, which could possibly inhibit MER3 by having downstream effects on DNA repair pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor known to influence DNA repair mechanisms, which could possibly inhibit MER3's function. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $357.00 | 10 | |
NU7441 is a potent DNA-PK inhibitor, which could possibly inhibit MER3's role in DNA repair through its influence on the NHEJ pathway. | ||||||